Nxera Pharma
Japan - Tokyo
PharmaceuticalFocus: Umbrella Company
Nxera Pharma is a life sciences company focused on Umbrella Company.
NeurologyOncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
HTL0030310
HealthyClinical Trials (1)
NCT03847207A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310
Phase 1HTL0014242
HealthyClinical Trials (1)
NCT04462263Study to Investigate the Receptor Occupancy of HTL0014242 Using [18F] FPEB in Healthy Male Subjects
Phase 1HTL0009936 modified release
Alzheimer's DiseaseClinical Trials (1)
NCT02710188Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation
Phase 1HTL0016878
Healthy SubjectsClinical Trials (1)
NCT04849286Measurement of HTL0016878 in Cerebrospinal Fluid
Phase 1HTL0016878.HCl Solution 10 mg
Healthy SubjectsClinical Trials (1)
NCT04935320Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution
Phase 1HTL0018318
Alzheimer's DiseaseClinical Trials (1)
NCT03456349Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care
Phase 1HTL0022562
HealthyClinical Trials (1)
NCT04941989A Study in Healthy Subjects to Assess the Safety, Tolerability and Pharmacokinetics of HTL0022562
Phase 1HTL0018318
Safety IssuesClinical Trials (1)
NCT03198624Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects
Phase 1HTL0009936
Alzheimer's DiseaseClinical Trials (1)
NCT02291783Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment
Phase 1HTL0009936
Alzheimer's DiseaseClinical Trials (1)
NCT02546310Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects
Phase 1HTL0018318
Bioavailability and PharmacokineticsClinical Trials (1)
NCT02958696Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules
Phase 1HTL0014242
HealthyClinical Trials (1)
NCT03785054Phase 1, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of mGlu5 NAM HTL0014242
Phase 1HTL0016878
HealthyClinical Trials (1)
NCT03244228A Two Part Study to Assess Safety, PK, PD, and Food Effect of Oral HTL0016878
Phase 1HTL0039732 Capsules
NeoplasmsClinical Trials (1)
NCT05944237HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2HTL0018318
Dementia With Lewy BodiesClinical Trials (1)
NCT03592862A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies
Phase 2Daridorexant
Insomnia DisorderClinical Trials (1)
NCT07028697A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 16 clinical trials